Introduction:Basic information about CAS 2380-63-4|4-Aminopyrazolo[3,4-d]pyrimidine, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 4-Aminopyrazolo[3,4-d]pyrimidine |
|---|
| CAS Number | 2380-63-4 | Molecular Weight | 193.671 |
|---|
| Density | 1.612g/cm3 | Boiling Point | 431.1ºC at 760mmHg |
|---|
| Molecular Formula | C5H5N5 | Melting Point | >325 °C(lit.) |
|---|
| MSDS | ChineseUSA | Flash Point | 244.4ºC |
|---|
| Symbol | GHS06 | Signal Word | Danger |
|---|
Names
| Name | 4-Aminopyrazolo[3,4-d]pyrimidine |
|---|
| Synonym | More Synonyms |
|---|
4-Aminopyrazolo[3,4-d]pyrimidine BiologicalActivity
| Description | Pyrazoloadenine is a potent RET (REarranged during Transfection) lung cancer oncoprotein inhibitor. Pyrazoloadenine shows anticancer activity[1][2]. |
|---|
| Related Catalog | Research Areas >>Cancer |
|---|
| In Vitro | Pyrazoloadenine inhibits a wide range of protein kinases such as BTK (Bruton’s tyrosine kinase), CDK1/2 (cyclin-dependent kinase 1/2), Src kinase, and RIPK1 (receptor-interacting protein kinase)[1]. |
|---|
Chemical & Physical Properties
| Density | 1.612g/cm3 |
|---|
| Boiling Point | 431.1ºC at 760mmHg |
|---|
| Melting Point | >325 °C(lit.) |
|---|
| Molecular Formula | C5H5N5 |
|---|
| Molecular Weight | 193.671 |
|---|
| Flash Point | 244.4ºC |
|---|
| Exact Mass | 193.086960 |
|---|
| PSA | 80.48000 |
|---|
| LogP | 0.51630 |
|---|
| InChIKey | LHCPRYRLDOSKHK-UHFFFAOYSA-N |
|---|
| SMILES | Nc1ncnc2[nH]ncc12 |
|---|
| Storage condition | -20°C Freezer |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- UR0717000
- CHEMICAL NAME :
- 1H-Pyrazolo(3,4-d)pyrimidine, 4-amino-
- CAS REGISTRY NUMBER :
- 2380-63-4
- BEILSTEIN REFERENCE NO. :
- 0005824
- LAST UPDATED :
- 199701
- DATA ITEMS CITED :
- 9
- MOLECULAR FORMULA :
- C5-H5-N5
- MOLECULAR WEIGHT :
- 135.15
- WISWESSER LINE NOTATION :
- T56 BMN GN INJ FZ
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 141 mg/kg
- TOXIC EFFECTS :
- Sense Organs and Special Senses (Eye) - ciliary spasm Sense Organs and Special Senses (Eye) - ptosis Behavioral - excitement
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 228 mg/kg
- TOXIC EFFECTS :
- Sense Organs and Special Senses (Eye) - ciliary spasm Sense Organs and Special Senses (Eye) - ptosis Behavioral - excitement
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 180 mg/kg
- TOXIC EFFECTS :
- Sense Organs and Special Senses (Eye) - ciliary spasm Sense Organs and Special Senses (Eye) - ptosis Behavioral - excitement
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 181 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD10 - Lethal Dose
- ROUTE OF EXPOSURE :
- Unreported
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 15 mg/kg
- TOXIC EFFECTS :
- Liver - other changes
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - cat
- DOSE/DURATION :
- 100 mg/kg
- TOXIC EFFECTS :
- Lungs, Thorax, or Respiration - other changes Gastrointestinal - changes in structure or function of salivary glands Kidney, Ureter, Bladder - urine volume increased
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 22500 mg/kg/9D-I
- TOXIC EFFECTS :
- Liver - fatty liver degeneration Blood - changes in bone marrow (not otherwise specified) Blood - changes in platelet count
MUTATION DATA - TYPE OF TEST :
- DNA inhibition
- TEST SYSTEM :
- Rodent - mouse Ascites tumor
- DOSE/DURATION :
- 5 umol/L
- REFERENCE :
- ECREAL Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- Volume(issue)/page/year: 48,319,1967
|
Safety Information
| Symbol | GHS06 |
|---|
| Signal Word | Danger |
|---|
| Hazard Statements | H301-H315-H319-H335 |
|---|
| Precautionary Statements | P261-P301 + P310-P305 + P351 + P338 |
|---|
| Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
|---|
| Hazard Codes | T:Toxic; |
|---|
| Risk Phrases | R23/24/25;R36/37/38 |
|---|
| Safety Phrases | S26-S36/37/39-S45-S22 |
|---|
| RIDADR | UN 2811 6.1/PG 3 |
|---|
| WGK Germany | 3 |
|---|
| RTECS | UR0717000 |
|---|
| Packaging Group | III |
|---|
| Hazard Class | 6.1 |
|---|
| HS Code | 2933990090 |
|---|
Customs
| HS Code | 2933990090 |
|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|---|
Articles30
More Articles
| Serotonergic regulation of excitability of principal cells of the dorsal cochlear nucleus. J. Neurosci. 35(11) , 4540-51, (2015) The dorsal cochlear nucleus (DCN) is one of the first stations within the central auditory pathway where the basic computations underlying sound localization are initiated and heightened activity in t... | |
| Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival. J. Clin. Invest. 124(6) , 2585-98, (2014) Activation of the ER stress response is associated with malignant progression of B cell chronic lymphocytic leukemia (CLL). We developed a murine CLL model that lacks the ER stress-associated transcri... | |
| Spectroscopic, electronic structure and natural bond analysis of 2-aminopyrimidine and 4-aminopyrazolo[3,4-d]pyrimidine: a comparative study. Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 96 , 226-41, (2012) The FTIR and FT-Raman spectra of 2-aminopyrimidine (2-AP) and 4-aminopyrazolo[3,4-d]pyrimidine (4-APP) has been recorded in the region 4000-400 and 3500-100 cm(-1), respectively. The tautomeric stabil... | |
Synonyms
| Methyl 3-piperidinylacetate hydrochloride (1:1) |
| 7-deaza-8-aza-adenine |
| 8-aza-7-deazaadenine |
| 1H-Pyrazolo[3,4-d]pyrimidin-4-amine |
| 1H-pyrazolo[3,4-d]pyrimidin-4-ylamine |
| EINECS 219-174-6 |
| pyrazolo[3,4-d]pyrimidin-4-amine |
| Pyrazoloadenine |
| Aminopurinol |
| 4-aminopyrazolo-(3,4-d)pyrimidine |
| 4-aminopyrazolo[5,4-d]pyrimidine |
| 4-Aminopyrazolopyrimidine |
| 1H-Pyrazolo[3,4-d]pyrimidine-4-ylamine 4-Amino-1H-pyrazolo[3,4-d]pyrimidine |
| Pyrazolo[3,4-d]pyrimidin-4-amin |
| 4-app |
| ADENINE ANTIMETABOLITE |
| MFCD00005688 |
| 3-Piperidineacetic acid, methyl ester, hydrochloride (1:1) |
| 4-AMINOPYRAZOLO{3,4-D}PYRIMIDINE |
| 1(H)-4-amine-pyrazolo[3,4-d]pyrimidine |
| 4-Amino pyrazolo[3,4-d]pyrimidine |